New Drugs Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease 4 years ago
Pharma Industry News UK study highlights potential of genetic screening for prostate cancer 4 years ago